The emerging role of TLR and innate immunity in cardiovascular disease

Cardiology Research and Practice

Volumn 1, Issue 1, 2012, Pages

  Spirig, Rolf ^a   Tsui, Janice ^b   Shaw, Sidney ^c  

^a CSL Behring AG   (Switzerland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTITHROMBIN III; COMPLEMENT COMPONENT C1S INHIBITOR; DEXTRAN SULFATE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT DEXTRAN SULFATE; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG TARGETING; GUILLAIN BARRE SYNDROME; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFLAMMATION; INNATE IMMUNITY; INSULIN RESISTANCE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; REPERFUSION INJURY; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 84861081512     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.1155/2012/181394     Document Type: Review

References (93)

1. Danese S., Dejana E., Fiocchi C., Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammat (Pubitemid 46717378)
2. Lemaitre B., Nicolas E., Michaut L., Reichhart J. M., Hoffmann J. A., The dorsoventral regulatory gene cassette spatzle/Toll/Cactus controls the potent antifungal response in Drosophila adults Cell 1996 86 6 973 983 (Pubitemid 26336801)
3. Medzhitov R., Preston-Hurlburt P., Janeway C. A. Jr., A human homologue of the Drosophila toll protein signals activation of adaptive immunity Nature 1997 388 6640 394 397 (Pubitemid 27334820)
4. Beutler B., Inferences, questions and possibilities in Toll-like receptor signalling Nature 2004 430 6996 257 263 (Pubitemid 38902439)
5. Alegre M. L., Leemans J., Le Moine A., Florquin S., De Wilde V., Chong A., Goldman M., The multiple facets of toll-like receptors in transplantation biology Transplantation 2008 86 1 1 9
6. Akira S., Takeda K., Toll-like receptor signalling Nature Reviews Immunology 2004 4 7 499 511 (Pubitemid 38931765)
7. O'Neill L. A. J., How Toll-like receptors signal: what we know and what we don't know Current Opinion in Immunology 2006 18 1 3 9 (Pubitemid 43049641)
8. Kaisho T., Takeuchi O., Kawai T., Hoshino K., Akira S., Endotoxin-induced maturation of MyD88-deficient dendritic cells Journal of Immunology 2001 166 9 5688 5694 (Pubitemid 32374193)
9. Kawai T., Takeuchi O., Fujita T., Inoue J.-I., Mhlradt P. F., Sato S., Hoshino K., Akira S., Lipopolysaccharide stimulates the MyaD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes Journal of Immunology 2001 167 10 5887 5894 (Pubitemid 33062783)
10. Taylor K. R., Yamasaki K., Radek K. A., Di Nardo A., Goodarzi H., Golenbock D., Beutler B., Gallo R. L., Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on toll-like receptor 4, CD44, and MD-2 Journal of Biological Chemistry 2007 282 25 18265 18275 (Pubitemid 47100227)
11. Matzinger P., Tolerance, danger, and the extended family Annual Review of Immunology 1994 12 991 1045 (Pubitemid 24140436)
12. Gallucci S., Lolkema M., Matzinger P., Natural adjuvants: endogenous activators of dendritic cells Nature Medicine 1999 5 11 1249 1255 (Pubitemid 29535601)
13. Lin E., Freedman J. E., Beaulieu L. M., Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases Cardiovascular Therapeutics 2009 27 2 117 123
14. Kono H., Rock K. L., How dying cells alert the immune system to danger Nature Reviews Immunology 2008 8 4 279 289 (Pubitemid 351432799)
15. Chen G. Y., Nuez G., Sterile inflammation: sensing and reacting to damage Nature Reviews Immunology 2010 10 12 826 837
16. Higashimori M., Tatro J. B., Moore K. J., Mendelsohn M. E., Galper J. B., Beasley D., Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 1 50 57
17. Gu J.-Q., Wang D.-F., Yan X.-G., Zhong W.-L., Zhang J., Fan B., Ikuyama S., A Toll-like receptor 9-mediated pathway stimulates perilipin 3 (TIP47) expression and induces lipid accumulation in macrophages American Journal of Physiology 2010 299 4 E593 E600
18. LeBouder E., Rey-Nores J. E., Rushmere N. K., Grigorov M., Lawn S. D., Affolter M., Griffin G. E., Ferrara P., Schiffrin E. J., Morgan B. P., Labéta M. O., Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk Journal of Immunology 2003 171 12 6680 6689 (Pubitemid 37532100)
19. Ueland T., Espevik T., Kjekshus J., Gullestad L., Omland T., Squire I. B., Frland S. S., Mollnes T. E., Dickstein K., Aukrust P., Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction Journal of Cardiac Failure 2006 12 8 659 663 (Pubitemid 44540257)
20. Cole J. E., Navin T. J., Cross A. J., Goddard M. E., Alexopoulou L., Mitra A. T., Davies A. H., Flavell R. A., Feldmann M., Monaco C., Unexpected protective role for Toll-like receptor 3 in the arterial wall Proceedings of the National Academy of Sciences of the United States of America 2011 108 6 2372 2377
21. Shi H., Kokoeva M. V., Inouye K., Tzameli I., Yin H., Flier J. S., TLR4 links innate immunity and fatty acid-induced insulin resistance Journal of Clinical Investigation 2006 116 11 3015 3025 (Pubitemid 44684486)
22. Tarkowski A., Bjersing J., Shestakov A., Bokarewa M. I., Resistin competes with lipopolysaccharide for binding to Toll-like receptor 4 Journal of Cellular and Molecular Medicine 2010 14 6 1419 1431
23. Buraczynska M., Baranowicz-Gaszczyk I., Tarach J., Ksiazek A., Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes Human Immunology 2009 70 2 121 124
24. Devaraj S., Jialal I., Yun J. M., Bremer A., Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications Metabolism 2011 60 2 256 259
25. Hodgkinson C. P., Laxton R. C., Patel K., Ye S., Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 12 2275 2281
26. Kaczorowski D. J., Nakao A., Mollen K. P., Vallabhaneni R., Sugimoto R., Kohmoto J., Tobita K., Zuckerbraun B. S., McCurry K. R., Murase N., Billiar T. R., Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion Transplantation 2007 84 10 1279 1287 (Pubitemid 351339316)
27. Favre J., Musette P., Douin-Echinard V., Laude K., Henry J. P., Arnal J. F., Thuillez C., Richard V., Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 5 1064 1071 (Pubitemid 46641958)
28. Zhao P., Wang J., He L., Ma H., Zhang X., Zhu X., Dolence E. K., Ren J., Li J., Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemia Journal of Cellular and Molecular Medicine 2009 13 8 1513 1525
29. Ha T., Hu Y., Liu L., Lu C., McMullen J. R., Kelley J., Kao R. L., Williams D. L., Gao X., Li C., TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism Cardiovascular Research 2010 87 4 694 703
30. Zhang M., Alicot E. M., Chiu I., Li J., Verna N., Vorup-Jensen T., Kessler B., Shimaoka M., Chan R., Friend D., Mahmood U., Weissleder R., Moore F. D., Carroll M. C., Identification of the target self-antigens in reperfusion injury Journal of Experimental Medicine 2006 203 1 141 152 (Pubitemid 43139653)
31. Hawlisch H., Belkaid Y., Baelder R., Hildeman D., Gerard C., Khl J., C5a negatively regulates toll-like receptor 4-induced immune responses Immunity 2005 22 4 415 426 (Pubitemid 40545108)
32. Zhang X., Kimura Y., Fang C., Zhou L., Sfyroera G., Lambris J. D., Wetsel R. A., Miwa T., Song W. C., Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo Blood 2007 110 1 228 236 (Pubitemid 47026839)
33. Spirig R., Van Kooten C., Obregon C., Nicod L., Daha M., Rieben R., The complement inhibitor low molecular weight dextran sulfate prevents TLR4-induced phenotypic and functional maturation of human dendritic cells Journal of Immunology 2008 181 2 878 890
34. Castellano G., Woltman A. M., Nauta A. J., Roos A., Trouw L. A., Seelen M. A., Schena F. P., Daha M. R., Van Kooten C., Maturation of dendritic cells abrogates C1q production in vivo and in vitro Blood 2004 103 10 3813 3820 (Pubitemid 38596300)
35. Baruah P., Dumitriu I. E., Peri G., Russo V., Mantovani A., Manfredi A. A., Rovere-Querini P., The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells Journal of Leukocyte Biology 2006 80 1 87 95 (Pubitemid 44835529)
36. Baruah P., Dumitriu I. E., Malik T. H., Cook H. T., Dyson J., Scott D., Simpson E., Botto M., C1q enhances IFN-7 production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells Blood 2009 113 15 3485 3493
37. Spirig R., Djafarzadeh S., Regueira T., Shaw S. G., von Garnier C., Takala J., Jakob S. M., Rieben R., Lepper P. M., Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1 and dendritic cell maturation under normoxic conditions PLoS One 2010 5 6
38. Jantsch J., Chakravortty D., Turza N., Prechtel A. T., Buchholz B., Gerlach R. G., Volke M., Glsner J., Warnecke C., Wiesener M. S., Eckardt K.-U., Steinkasserer A., Hensel M., Willam C., Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function Journal of Immunology 2008 180 7 4697 4705
39. Brunner F., Du Toit E. F., Opie L. H., Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts Journal of Molecular and Cellular Cardiology 1992 24 11 1291 1305 (Pubitemid 23016052)
40. Ehrenreich H., Anderson R. W., Fox C. H., Rieckmann P., Hoffman G. S., Travis W. D., Coligan J. E., Kehrl J. H., Fauci A. S., Endothelins, peptides with potent vasoactive properties, are produced by human macrophages Journal of Experimental Medicine 1990 172 6 1741 1748
41. Spirig R., Potapova I., Shaw-Boden J., Tsui J., Rieben R., Shaw S. G., TLR2 and TLR4 agonists induce production of the vasoactive peptide endothelin-1 by human dendritic cells Molecular Immunology 2009 46 15 3178 3182
42. Arslan F., Smeets M. B., O'Neill L. A. J., Keogh B., McGuirk P., Timmers L., Tersteeg C., Hoefer I. E., Doevendans P. A., Pasterkamp G., De Kleijn D. P. V., Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody Circulation 2010 121 1 80 90
43. Shimamoto A., Chong A. J., Yada M., Shomura S., Takayama H., Fleisig A. J., Agnew M. L., Hampton C. R., Rothnie C. L., Spring D. J., Pohlman T. H., Shimpo H., Verrier E. D., Inhibition of toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury Circulation 2006 114 1 I270 I274
44. Pangburn M. K., Atkinson M. A. L., Meri S., Localization of the heparin-binding site on complement factor H Journal of Biological Chemistry 1991 266 25 16847 16853 (Pubitemid 21907877)
45. Wuillemin W. A., Te Velthuis H., Lubbers Y. T. P., De Ruig C. P., Eldering E., Hack C. E., Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma Journal of Immunology 1997 159 4 1953 1960 (Pubitemid 127484185)
46. Wuillemin W. A., Eldering E., Citarella F., De Ruig C. P., Cate H. T., Erik Hack C., Modulation of contact system proteases by glycosaminoglycans: selective enhancement of the inhibition of factor XIa Journal of Biological Chemistry 1996 271 22 12913 12918 (Pubitemid 26175865)
47. Zeerleder S., Mauron T., Lmmle B., Wuillemin W. A., Effect of low-molecular weight dextran sulfate on coagulation and platelet function tests Thrombosis Research 2002 105 5 441 446 (Pubitemid 34621262)
48. Banz Y., Hess O. M., Robson S. C., Mettler D., Meier P., Haeberli A., Csizmadia E., Korchagina E. Y., Bovin N. V., Rieben R., Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury European Heart Journal 2005 26 21 2334 2343 (Pubitemid 41541401)
49. Gajanayake T., Sawitzki B., Matozan K., Korchagina E. Y., Lehmann M., Volk H. D., Rieben R., Dextran sulfate facilitates anti-CD4 mAb-induced long-term rat cardiac allograft survival after prolonged cold ischemia American Journal of Transplantation 2008 8 6 1151 1162 (Pubitemid 351763691)
50. Millard A. L., Spirig R., Mueller N. J., Seebach J. D., Rieben R., Inhibition of direct and indirect TLR-mediated activation of human NK cells by low molecular weight dextran sulfate Molecular Immunology 2010 47 14 2349 2358
51. Platt J. L., Vercellotti G. M., Lindman B. J., Oegema T. R. Jr., Bach F. H., Dalmasso A. P., Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection Journal of Experimental Medicine 1990 171 4 1363 1368 (Pubitemid 20120153)
52. Platt J. L., Dalmasso A. P., Lindman B. J., Ihrcke N. S., Bach F. H., The role of C5a and antibody in the release of heparan sulfate from endothelial cells European Journal of Immunology 1991 21 11 2887 2890
53. Ihrcke N. S., Platt J. L., Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules Journal of Cellular Physiology 1996 168 3 625 637 (Pubitemid 26302869)
54. Ihrcke N. S., Parker W., Reissner K. J., Platt J. L., Regulation of platelet heparanase during inflammation: role of pH and proteinases Journal of Cellular Physiology 1998 175 3 255 267 (Pubitemid 28198205)
55. Rehm M., Bruegger D., Christ F., Conzen P., Thiel M., Jacob M., Chappell D., Stoeckelhuber M., Welsch U., Reichart B., Peter K., Becker B. F., Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia Circulation 2007 116 17 1896 1906 (Pubitemid 350287085)
56. Johnson G. B., Brunn G. J., Kodaira Y., Platt J. L., Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4 Journal of Immunology 2002 168 10 5233 5239 (Pubitemid 34495991)
57. Wrenshall L. E., Stevens R. B., Cerra F. B., Platt J. L., Modulation of macrophage and B cell function by glycosaminoglycans Journal of Leukocyte Biology 1999 66 3 391 400 (Pubitemid 29439245)
58. Wrenshall L. E., Cerra F. B., Singh R. K., Platt J. L., Heparan sulfate initiates signals in murine macrophages leading to divergent biologic outcomes Journal of Immunology 1995 154 2 871 880
59. Schmidt P., Magnusson C., Lundgren T., Korsgren O., Nilsson B., Low molecular weight dextran sulfate is well tolerated in humans and increases endogenous expression of islet protective hepatocyte growth factor Transplantation 2008 86 11 1523 1530
60. Nimmerjahn F., Ravetch J. V., Anti-inflammatory actions of intravenous immunoglobulin Annual Review of Immunology 2008 26 513 533 (Pubitemid 351600384)
61. Durandy A., Kaveri S. V., Kuijpers T. W., Basta M., Miescher S., Ravetch J. V., Rieben R., Intravenous immunoglobulins-understanding properties and mechanisms Clinical and Experimental Immunology 2009 158 supplement 1 2 13
62. Tha-In T., Metselaar H. J., Bushell A. R., Kwekkeboom J., Wood K. J., Intravenous immunoglobulins promote skin allograft acceptance by triggering functional activation of CD4+Foxp3+ T cells Transplantation 2010 89 12 1446 1455
63. Mohacsi P., Rieben R., Sigurdsson G., Tschanz H., Schaffner T., Nydegger U. E., Carrel T., Successful management of a B-type cardiac allograft into an O-type man with 3 1/2-year clinical follow-up Transplantation 2001 72 7 1328 1330 (Pubitemid 33026618)
64. Bayry J., Lacroix-Desmazes S., Carbonneil C., Misra N., Donkova V., Pashov A., Chevailler A., Mouthon L., Weill B., Bruneval P., Kazatchkine M. D., Kaveri S. V., Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin Blood 2003 101 2 758 765 (Pubitemid 36077604)
65. Ballow M., Allen C., Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytes Clinical Immunology 2011 139 208 214
66. Kessel A., Peri R., Haj T., Snir A., Slobodin G., Sabo E., Rosner I., Shoenfeld Y., Toubi E., IVIg attenuates TLR-9 activation in B cells from SLE patients Journal of Clinical Immunology 2011 32 30 38
67. Davis A. E., Mejia P., Lu F., Biological activities of C1 inhibitor Molecular Immunology 2008 45 16 4057 4063
68. Horstick G., Berg O., Heimann A., Gtze O., Loos M., Hafner G., Bierbach B., Petersen S., Bhakdi S., Darius H., Horstick M., Meyer J., Kempski O., Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects Circulation 2001 104 25 3125 3131 (Pubitemid 34014069)
69. Buerke M., Murohara T., Lefer A. M., Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion Circulation 1995 91 2 393 402
70. Liu D., Cai S., Gu X., Scafidi J., Wu X., Davis A. E. III, C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide Journal of Immunology 2003 171 5 2594 2601 (Pubitemid 37025571)
71. Liu D., Gu X., Scafidi J., Davis A. E. III, N-linked glycosylation is required for C1 inhibitor-mediated protection from endotoxin shock in mice Infection and Immunity 2004 72 4 1946 1955 (Pubitemid 38419905)
72. Bergamaschini L., Gobbo G., Gatti S., Caccamo L., Prato P., Maggioni M., Braidotti P., Di Stefano R., Fassati L. R., Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver Clinical and Experimental Immunology 2001 126 3 412 420 (Pubitemid 34008711)
73. Patnaik M. M., Moll S., Inherited antithrombin deficiency: a review Haemophilia 2008 14 6 1229 1239
74. Ostrovsky L., Woodman R. C., Payne D., Teoh D., Kubes P., Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion Circulation 1997 96 7 2302 2310 (Pubitemid 27425837)
75. Mansell A., Reinicke A., Worrall D. M., O'Neill L. A. J., The serine protease inhibitor antithrombin III inhibits LPS-mediated NF- B activation by TLR-4 FEBS Letters 2001 508 3 313 317 (Pubitemid 33135461)
76. Aramaki O., Takayama T., Yokoyama T., Takano S., Akiyama Y., Shibutani S., Matsumoto K., Shimazu M., Kitajima M., Ikeda Y., Shirasugi N., Niimi M., High dose of antithrombin III induces indefinite survival of fully allogeneic cardiac grafts and generates regulatory cells Transplantation 2003 75 2 217 220 (Pubitemid 36139675)
77. Silverman E. K., Sandhaus R. A., Alpha 1 -antitrypsin deficiency New England Journal of Medicine 2009 360 26 2749 2757
78. Churg A., Dai J., Zay K., Karsan A., Hendricks R., Yee C., Martin R., MacKenzie R., Xie C., Zhang L., Shapiro S., Wright J. L., Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects Laboratory Investigation 2001 81 8 1119 1131 (Pubitemid 32772072)
79. Nita I. M., Serapinas D., Janciauskiene S. M., 1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro International Journal of Biochemistry and Cell Biology 2007 39 6 1165 1176 (Pubitemid 46819133)
80. Toldo S., Seropian I. M., Mezzaroma E., Van Tassell B. W., Salloum F. N., Lewis E. C., Voelkel N., Dinarello C. A., Abbate A., Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury Journal of Molecular and Cellular Cardiology 2011 51 2 244 251
81. Johnson G. B., Brunn G. J., Platt J. L., Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4 Journal of Immunology 2004 172 1 20 24 (Pubitemid 38020450)
82. Wadham C., Albanese N., Roberts J., Wang L., Bagley C. J., Gamble J. R., Rye K. A., Barter P. J., Vadas M. A., Xia P., High-density lipoproteins neutralize C-reactive protein proinflammatory activity Circulation 2004 109 17 2116 2122 (Pubitemid 38620221)
83. Viswambharan H., Ming X. F., Zhu S., Hubsch A., Lerch P., Vergres G., Rusconi S., Yang Z., Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase Circulation Research 2004 94 7 918 925 (Pubitemid 38490069)
84. Shaw J. A., Bobik A., Murphy A., Kanellakis P., Blombery P., Mukhamedova N., Woollard K., Lyon S., Sviridov D., Dart A. M., Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque Circulation Research 2008 103 10 1084 1091
85. Calabresi L., Rossoni G., Gomaraschi M., Sisto F., Berti F., Franceschini G., High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor- content and enhancing prostaglandin release Circulation Research 2003 92 3 330 337 (Pubitemid 36258556)
86. Kiya Y., Miura S. I., Imaizumi S., Uehara Y., Matsuo Y., Abe S., Jimi S., Urata H., Rye K. A., Saku K., Reconstituted high-density lipoprotein attenuates postinfarction left ventricular remodeling in rats Atherosclerosis 2009 203 1 137 144
87. Pajkrt D., Doran J. E., Koster F., Lerch P. G., Arnet B., Van Der Poll T., Ten Cate J. W., Van Deventer S. J. H., Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia Journal of Experimental Medicine 1996 184 5 1601 1608 (Pubitemid 26404453)
88. Kobashigawa J. A., Statins in solid organ transplantation: is there an immunosuppressive effect? American Journal of Transplantation 2004 4 7 1013 1018 (Pubitemid 38868589)
89. Methe H., Kim J.-O., Kofler S., Nabauer M., Weis M., Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14 + monocytes Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 7 1439 1445 (Pubitemid 40923365)
90. Yilmaz A., Reiss C., Weng A., Cicha I., Stumpf C., Steinkasserer A., Daniel W. G., Garlichs C. D., Differential effects of statins on relevant functions of human monocyte-derived dendritic cells Journal of Leukocyte Biology 2006 79 3 529 538 (Pubitemid 44831230)
91. Mahaffey K. W., Granger C. B., Nicolau J. C., Ruzyllo W., Weaver W. D., Theroux P., Hochman J. S., Filloon T. G., Mojcik C. F., Todaro T. G., Armstrong P. W., Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial Circulation 2003 108 10 1176 1183 (Pubitemid 37099984)
92. Laumonier T., Mohacsi P. J., Matozan K. M., Banz Y., Haeberli A., Korchagina E. Y., Bovin N. V., Vanhove B., Rieben R., Endothelial cell protection by dextran sulfate: a novel strategy to prevent acute vascular rejection in xenotransplantation American Journal of Transplantation 2004 4 2 181 187 (Pubitemid 38248520)
93. Stenestrand U., Wallentin L., Early statin treatment following acute myocardial infarction and 1-year survival Journal of the American Medical Association 2001 285 4 430 436 (Pubitemid 32097261)